Obsessive-Compulsive Disorder During the COVID-19 Pandemic: a Systematic Review.
Andrew G GuzickAbigail CandelariAndrew D WieseSophie C SchneiderWayne K GoodmanEric A StorchPublished in: Current psychiatry reports (2021)
Most studies showed that obsessive-compulsive symptoms worsened during the early stages of the pandemic, particularly for individuals with contamination-related obsessive-compulsive disorder (OCD), though other symptoms dimensions were found to worsen as well. Many patients and individuals in the general population experienced new obsessive-compulsive-like symptoms centered on COVID-19. Self-reported rates of symptom exacerbation and COVID-19-focused symptoms were consistently lower in studies that recruited patients from specialty clinics (compared to online samples). Most studies were conducted in Spring/Summer, 2020. The COVID-19 pandemic has been an enormous stressor for individuals with OCD, especially for those with contamination symptoms. Regardless, there is strong reason to believe gold standard treatment approaches for OCD have maintained strong efficacy. Disseminating and effectively delivering evidence-based treatments for OCD is an urgent public health priority.
Keyphrases
- obsessive compulsive disorder
- deep brain stimulation
- sars cov
- coronavirus disease
- end stage renal disease
- public health
- ejection fraction
- newly diagnosed
- chronic kidney disease
- sleep quality
- healthcare
- risk assessment
- drinking water
- peritoneal dialysis
- chronic obstructive pulmonary disease
- prognostic factors
- social media
- intensive care unit
- case control
- health risk
- patient reported
- climate change
- physical activity
- heat stress
- heavy metals
- extracorporeal membrane oxygenation
- replacement therapy